Ultrasound Assisted in Tumor Immunotherapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 20 April 2024 | Viewed by 1146
Special Issue Editors
Interests: ultrasound; microbubble; nanodroplet; drug delivery; tumor microenvironment; immunotherapy; ischemia-reperfusion injury
Interests: ultrasound contrast agent; tumor microenvironment; biomedical applications of shear wave elastography
Special Issue Information
Dear Colleagues,
Tumor immunotherapy hottest issue in modern cancer research. Systemic anti-tumor immunomodulation has been developed by various strategies to improve the treatment outcomes in metastatic or drug/radiation-resistant tumors. Ultrasound provides not only real-time diagnosis but also local therapy which has been widely applied in cancer therapeutic applications. The acoustic thermal or cavitation effect (with ultrasound-responsive particles) promotes antigen production and immune cell activation, in addition to activating immune cell infiltration with the aim of accomplishing anti-tumor immunotherapy. Moreover, the application of ultrasound technology combined with immune-activated drugs/genes/gases has been proposed as possibility regulating the tumor microenvironment from a state of immunosuppression into immunoactivation. Thus, we consider that ultrasound-induced thermal or cavitation effect provided a potential way to promote anti-tumor immune responses via tumor microenvironment modulation.
This Special Issue aims to highlight all the latest developments in “ultrasound-assisted in tumor immunotherapy”.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Ultrasound-induced immunotherapy and immune cell activation;
- Fabrication of immune-activated drug-loaded ultrasound-responsive particles;
- Acoustic thermal or cavitation effect for tumor immunotherapy;
- Immune responses induced by sonodynamic therapy;
- Focused ultrasound for immunomodulation in tumor microenvironment;
- Immune responses after focused ultrasound induced blood–brain barrier opening;
- Ultrasound-mediated tumor vaccination.
I/We look forward to receiving your contributions.
Dr. Yi-Ju Ho
Dr. Wei-Wen Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ultrasound
- immunotherapy
- tumor microenvironment
- thermal effect
- cavitation effect
- micro/nano-bubble
- micro/nano-droplet
- permeability
- therapeutics